Sardu, C.; Santulli, G.; Guerra, G.; Trotta, M.C.; Santamaria, M.; Sacra, C.; Testa, N.; Ducceschi, V.; Gatta, G.; D' Amico, M.;
et al. Modulation of SERCA in Patients with Persistent Atrial Fibrillation Treated by Epicardial Thoracoscopic Ablation: The CAMAF Study. J. Clin. Med. 2020, 9, 544.
https://doi.org/10.3390/jcm9020544
AMA Style
Sardu C, Santulli G, Guerra G, Trotta MC, Santamaria M, Sacra C, Testa N, Ducceschi V, Gatta G, D' Amico M,
et al. Modulation of SERCA in Patients with Persistent Atrial Fibrillation Treated by Epicardial Thoracoscopic Ablation: The CAMAF Study. Journal of Clinical Medicine. 2020; 9(2):544.
https://doi.org/10.3390/jcm9020544
Chicago/Turabian Style
Sardu, Celestino, Gaetano Santulli, Germano Guerra, Maria Consiglia Trotta, Matteo Santamaria, Cosimo Sacra, Nicola Testa, Valentino Ducceschi, Gianluca Gatta, Michele D' Amico,
and et al. 2020. "Modulation of SERCA in Patients with Persistent Atrial Fibrillation Treated by Epicardial Thoracoscopic Ablation: The CAMAF Study" Journal of Clinical Medicine 9, no. 2: 544.
https://doi.org/10.3390/jcm9020544
APA Style
Sardu, C., Santulli, G., Guerra, G., Trotta, M. C., Santamaria, M., Sacra, C., Testa, N., Ducceschi, V., Gatta, G., D' Amico, M., Sasso, F. C., Paolisso, G., & Marfella, R.
(2020). Modulation of SERCA in Patients with Persistent Atrial Fibrillation Treated by Epicardial Thoracoscopic Ablation: The CAMAF Study. Journal of Clinical Medicine, 9(2), 544.
https://doi.org/10.3390/jcm9020544